S. Kary - Concepedia

Concepedia

Author

S. Kary

Charité - Universitätsmedizin Berlin

Also Known As

Kary, S., Kary, Sonja, S Kary, S. Kary, SONJA KARY, Sonja Kary, U. Oezer, W. G. Dixon

40

Publications

2.9K

Citations

19

H-Index

19

Concepts

All Affiliations

Charité - Universitätsmedizin Berlin Abbott (Germany)Franklin University Assistance Publique – Hôpitaux de Paris German Rheumatism Research Centre

SK

About

S. Kary is an author at Charité - Universitätsmedizin Berlin specializing in chronic inflammation, allergy, and immune regulation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	46
2	Allergy	1	1	46
3	Immunology	1	1	46
4	Pharmacology	1	1	46
5	Rheumatology	1	1	46

S. Kary

×

19

Publications

2.9K

Citations

19

H-Index

	Year	Citations
Infections in patients with rheumatoid arthritis treated with biologic agents Joachim Listing, Anja Strangfeld, S. Kary, Arthritis & Rheumatism	2005	684
Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study Martín Rudwaleit, E Rødevand, Peter Holck, Annals of the Rheumatic Diseases	2008	284
Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-? antagonists H-H. Lee, I.‐H. Song, M. Friedrich, British Journal of Dermatology	2007	247
Effectiveness, Safety, and Predictors of Good Clinical Response in 1250 Patients Treated with Adalimumab for Active Ankylosing Spondylitis Martín Rudwaleit, Pascal Claudepierre, P Wordsworth, The Journal of Rheumatology	2009	217
Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial Gerd R Burmester, X. Mariette, Carlomaurizio Montecucco, Annals of the Rheumatic Diseases	2007	196
Effectiveness of adalimumab for rheumatoid arthritis in patients with a history of TNF-antagonist therapy in clinical practice Stefano Bombardieri, A. A. Ruiz, Patrice Fardellone, Lara D. Veeken	2007	178
Treatment continuation in patients receiving biological agents or conventional DMARD therapy A. Zink, Joachim Listing, S. Kary, Annals of the Rheumatic Diseases	2005	151
Oral type II collagen treatment in early rheumatoid arthritis. A double‐blind, placebo‐controlled, randomized trial Joachim Sieper, S. Kary, H. Sörensen, Arthritis & Rheumatism	1996	146
New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor α antagonists S. Kary Annals of the Rheumatic Diseases	2005	127
Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions Filip Van den Bosch, Bernhard Manger, Philippe Goupille, Annals of the Rheumatic Diseases	2009	126

Page 1